Literature DB >> 1504094

Promotion of beta-structure by interaction of diabetes associated polypeptide (amylin) with phosphatidylcholine.

L R McLean1, A Balasubramaniam.   

Abstract

The interaction of the diabetes associated polypeptide (amylin) with dimyristoylphosphatidylcholine (DMPC) was assessed by measurements of turbidity (absorbance at 400 nm) and secondary structure by CD spectroscopy. In trifluoroethanol, human amylin adopts a highly alpha-helical conformation while the rat peptide is less structured. In water, the rat peptide is largely disordered and the human peptide exhibits a combination of alpha- and beta-structures. Mixtures of DMPC and the rat peptide have no effect on either the turbidity of the DMPC or the CD spectrum of the peptide. By contrast, mixtures of the human peptide with DMPC form relatively clear mixtures similar to those observed with amphipathic alpha-helical peptides, but the structure adopted, based on the CD spectrum, is largely beta. These data demonstrate that fundamental differences in the structures adopted by amylins from human and rat species exist in mixtures with DMPC and suggest that these differences may be related to the formation of amyloid fibrils in the human amylin peptide which are not observed in the rat peptide.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1504094     DOI: 10.1016/0167-4838(92)90411-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

Review 1.  Membranes as modulators of amyloid protein misfolding and target of toxicity.

Authors:  Anoop Rawat; Ralf Langen; Jobin Varkey
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-04-25       Impact factor: 3.747

2.  Solution state structures of human pancreatic amylin and pramlintide.

Authors:  John R Cort; Zhihong Liu; Gregory M Lee; K N L Huggins; Susan Janes; Kathryn Prickett; Niels H Andersen
Journal:  Protein Eng Des Sel       Date:  2009-07-12       Impact factor: 1.650

3.  Human islet amyloid polypeptide at the air-aqueous interface: a Langmuir monolayer approach.

Authors:  Shanghao Li; Miodrag Micic; Jhony Orbulescu; Jeffrey D Whyte; Roger M Leblanc
Journal:  J R Soc Interface       Date:  2012-07-11       Impact factor: 4.118

Review 4.  Amyloid peptide channels.

Authors:  B L Kagan; R Azimov; R Azimova
Journal:  J Membr Biol       Date:  2004-11       Impact factor: 1.843

5.  Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity.

Authors:  S Doré; S Kar; R Quirion
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

6.  Conformational Dynamics of the Human Islet Amyloid Polypeptide in a Membrane Environment: Toward the Aggregation Prone Form.

Authors:  Katrine Kirkeby Skeby; Ole Juul Andersen; Taras V Pogorelov; Emad Tajkhorshid; Birgit Schiøtt
Journal:  Biochemistry       Date:  2016-03-22       Impact factor: 3.162

7.  Two-dimensional infrared spectroscopy provides evidence of an intermediate in the membrane-catalyzed assembly of diabetic amyloid.

Authors:  Yun L Ling; David B Strasfeld; Sang-Hee Shim; Daniel P Raleigh; Martin T Zanni
Journal:  J Phys Chem B       Date:  2009-02-26       Impact factor: 2.991

8.  Amyloid peptides are toxic via a common oxidative mechanism.

Authors:  D Schubert; C Behl; R Lesley; A Brack; R Dargusch; Y Sagara; H Kimura
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

9.  Mistic: cellular localization, solution behavior, polymerization, and fibril formation.

Authors:  Hay Dvir; Matthew E Lundberg; Samir K Maji; Roland Riek; Senyon Choe
Journal:  Protein Sci       Date:  2009-07       Impact factor: 6.725

Review 10.  Recent insights in islet amyloid polypeptide-induced membrane disruption and its role in beta-cell death in type 2 diabetes mellitus.

Authors:  Lucie Khemtémourian; J Antoinette Killian; Jo W M Höppener; Maarten F M Engel
Journal:  Exp Diabetes Res       Date:  2008
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.